ORIC Pharmaceuticals, Inc.
Inhibitors of glucocorticoid receptor
Last updated:
Abstract:
The present invention relates generally to compositions and methods for treating cancer and hypercortisolism. Provided herein are substituted steroidal derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition of glucocorticoid receptors. Furthermore, the subject compounds and compositions are useful for the treatment of cancer.
Status:
Grant
Type:
Utility
Filling date:
1 Jun 2020
Issue date:
17 Nov 2020